MAGN:NYSEMagnera Corporation Analysis
Data as of 2026-08-23 - not real-time
$12.34
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind Magnera Corporation is bullish at $12.34, with short-term averages leading the long-term ones. The last 30 days have lost 4.3%. With RSI at 45.5 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near $11.69 and resistance around $14.32.
Multiples put this in undervalued territory at a P/E of 7.6. Consensus targets land 25.6% above where the shares trade now. Revenue is growing at 2.1% on a -3.4% profit margin.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 49.1%, a beta of 1.19 and a maximum drawdown of 41.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Multiples put this in undervalued territory at a P/E of 7.6. Consensus targets land 25.6% above where the shares trade now. Revenue is growing at 2.1% on a -3.4% profit margin.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 49.1%, a beta of 1.19 and a maximum drawdown of 41.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Top Market Events
Magnera MAGN is scheduled to announce Q3 earnings results on Thursday, August 6th, before market open.Seeking Alpha17dMagnera Corporation MAGN Q3 2026 Earnings Call TranscriptThank you.10dMagnera Corporation: Executing But AbandonedMagnera is executing well post-merger, integrating operations, growing...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 12.21
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 12.21
- Analyst targets imply +25.6% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Negative profit margin of -3.4%
- Analyst targets imply +25.6% versus the current price
- Negative return on equity of -10.4%
Key Metrics & Analysis
Financial Health
Revenue Growth2.10%
Profit Margin-3.41%
P/E Ratio7.6
ROE-10.43%
ROA2.27%
Debt/Equity192.82
P/B Ratio0.4
Op. Cash Flow$172.0M
Free Cash Flow$230.0M
Technical Analysis
TrendBullish
RSI45.5
Support$11.69
Resistance$14.32
MA 20$12.89
MA 50$12.78
MA 200$12.21
MACDBearish
VolumeDecreasing
Fear & Greed Index94.41
Valuation
Fair Value$43.32
Target Price$15.50
Upside/Downside25.61%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.19
Volatility49.15%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.